調査レポート | • レポートコード：QYR2104Z1426 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、認知・記憶増強薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アリセプト、エクセロン、ナメンダ、ラザダイン、プロビジル、リタリン、アデロール、その他）、用途別市場規模（疾病治療、学業成績、運動能力、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・認知・記憶増強薬の市場動向 ・企業の競争状況、市場シェア ・認知・記憶増強薬の種類別市場規模（アリセプト、エクセロン、ナメンダ、ラザダイン、プロビジル、リタリン、アデロール、その他） ・認知・記憶増強薬の用途別市場規模（疾病治療、学業成績、運動能力、その他） ・認知・記憶増強薬の北米市場規模2016-2027（アメリカ、カナダ） ・認知・記憶増強薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・認知・記憶増強薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・認知・記憶増強薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・認知・記憶増強薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eisai Co、Allergan、Novartis、Takeda、Johnson & Johnson、Takeda Pharmaceutical Company Limited、AlternaScript、Cephalon、Ceretropic） ・結論 |
Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer’s disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.
Market Analysis and Insights: Global Cognitive and Memory Enhancer Drugs Market
The global Cognitive and Memory Enhancer Drugs market size is projected to reach US$ 5682.4 million by 2026, from US$ 4056.6 million in 2019, at a CAGR of 4.9% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cognitive and Memory Enhancer Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cognitive and Memory Enhancer Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cognitive and Memory Enhancer Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cognitive and Memory Enhancer Drugs market.
Global Cognitive and Memory Enhancer Drugs Scope and Market Size
Cognitive and Memory Enhancer Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cognitive and Memory Enhancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others
Segment by Application
Disease Treatment
Academic Performance
Athletic Performance
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Eisai Co
Allergan
Novartis
Takeda
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript
Cephalon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Aricept
1.2.3 Exelon
1.2.4 Namenda
1.2.5 Razadyne
1.2.6 Provigil
1.2.7 Ritalin
1.2.8 Adderall
1.2.9 Others
1.3 Market by Application
1.3.1 Global Cognitive and Memory Enhancer Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Disease Treatment
1.3.3 Academic Performance
1.3.4 Athletic Performance
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cognitive and Memory Enhancer Drugs Market Perspective (2016-2027)
2.2 Cognitive and Memory Enhancer Drugs Growth Trends by Regions
2.2.1 Cognitive and Memory Enhancer Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cognitive and Memory Enhancer Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Cognitive and Memory Enhancer Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Cognitive and Memory Enhancer Drugs Industry Dynamic
2.3.1 Cognitive and Memory Enhancer Drugs Market Trends
2.3.2 Cognitive and Memory Enhancer Drugs Market Drivers
2.3.3 Cognitive and Memory Enhancer Drugs Market Challenges
2.3.4 Cognitive and Memory Enhancer Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive and Memory Enhancer Drugs Players by Revenue
3.1.1 Global Top Cognitive and Memory Enhancer Drugs Players by Revenue (2016-2021)
3.1.2 Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Cognitive and Memory Enhancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cognitive and Memory Enhancer Drugs Revenue
3.4 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio
3.4.1 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive and Memory Enhancer Drugs Revenue in 2020
3.5 Cognitive and Memory Enhancer Drugs Key Players Head office and Area Served
3.6 Key Players Cognitive and Memory Enhancer Drugs Product Solution and Service
3.7 Date of Enter into Cognitive and Memory Enhancer Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive and Memory Enhancer Drugs Breakdown Data by Type
4.1 Global Cognitive and Memory Enhancer Drugs Historic Market Size by Type (2016-2021)
4.2 Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Type (2022-2027)
5 Cognitive and Memory Enhancer Drugs Breakdown Data by Application
5.1 Global Cognitive and Memory Enhancer Drugs Historic Market Size by Application (2016-2021)
5.2 Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cognitive and Memory Enhancer Drugs Market Size (2016-2027)
6.2 North America Cognitive and Memory Enhancer Drugs Market Size by Type
6.2.1 North America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021)
6.2.2 North America Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027)
6.2.3 North America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2027)
6.3 North America Cognitive and Memory Enhancer Drugs Market Size by Application
6.3.1 North America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021)
6.3.2 North America Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027)
6.3.3 North America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2027)
6.4 North America Cognitive and Memory Enhancer Drugs Market Size by Country
6.4.1 North America Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021)
6.4.2 North America Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cognitive and Memory Enhancer Drugs Market Size (2016-2027)
7.2 Europe Cognitive and Memory Enhancer Drugs Market Size by Type
7.2.1 Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021)
7.2.2 Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027)
7.2.3 Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2027)
7.3 Europe Cognitive and Memory Enhancer Drugs Market Size by Application
7.3.1 Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021)
7.3.2 Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027)
7.3.3 Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2027)
7.4 Europe Cognitive and Memory Enhancer Drugs Market Size by Country
7.4.1 Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021)
7.4.2 Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size (2016-2027)
8.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type
8.2.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application
8.3.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region
8.4.1 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cognitive and Memory Enhancer Drugs Market Size (2016-2027)
9.2 Latin America Cognitive and Memory Enhancer Drugs Market Size by Type
9.2.1 Latin America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2027)
9.3 Latin America Cognitive and Memory Enhancer Drugs Market Size by Application
9.3.1 Latin America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2027)
9.4 Latin America Cognitive and Memory Enhancer Drugs Market Size by Country
9.4.1 Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size (2016-2027)
10.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type
10.2.1 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application
10.3.1 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country
10.4.1 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Cognitive and Memory Enhancer Drugs Introduction
11.1.4 Pfizer Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eisai Co
11.2.1 Eisai Co Company Details
11.2.2 Eisai Co Business Overview
11.2.3 Eisai Co Cognitive and Memory Enhancer Drugs Introduction
11.2.4 Eisai Co Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.2.5 Eisai Co Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Cognitive and Memory Enhancer Drugs Introduction
11.3.4 Allergan Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cognitive and Memory Enhancer Drugs Introduction
11.4.4 Novartis Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Cognitive and Memory Enhancer Drugs Introduction
11.5.4 Takeda Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.5.5 Takeda Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Cognitive and Memory Enhancer Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical Company Limited
11.7.1 Takeda Pharmaceutical Company Limited Company Details
11.7.2 Takeda Pharmaceutical Company Limited Business Overview
11.7.3 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Introduction
11.7.4 Takeda Pharmaceutical Company Limited Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.7.5 Takeda Pharmaceutical Company Limited Recent Development
11.8 AlternaScript
11.8.1 AlternaScript Company Details
11.8.2 AlternaScript Business Overview
11.8.3 AlternaScript Cognitive and Memory Enhancer Drugs Introduction
11.8.4 AlternaScript Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.8.5 AlternaScript Recent Development
11.9 Cephalon
11.9.1 Cephalon Company Details
11.9.2 Cephalon Business Overview
11.9.3 Cephalon Cognitive and Memory Enhancer Drugs Introduction
11.9.4 Cephalon Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.9.5 Cephalon Recent Development
11.10 Ceretropic
11.10.1 Ceretropic Company Details
11.10.2 Ceretropic Business Overview
11.10.3 Ceretropic Cognitive and Memory Enhancer Drugs Introduction
11.10.4 Ceretropic Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021)
11.10.5 Ceretropic Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Aricept
Table 3. Key Players of Exelon
Table 4. Key Players of Namenda
Table 5. Key Players of Razadyne
Table 6. Key Players of Provigil
Table 7. Key Players of Ritalin
Table 8. Key Players of Adderall
Table 9. Key Players of Others
Table 10. Global Cognitive and Memory Enhancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Cognitive and Memory Enhancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Cognitive and Memory Enhancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Cognitive and Memory Enhancer Drugs Market Share by Regions (2016-2021)
Table 14. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Cognitive and Memory Enhancer Drugs Market Share by Regions (2022-2027)
Table 16. Cognitive and Memory Enhancer Drugs Market Trends
Table 17. Cognitive and Memory Enhancer Drugs Market Drivers
Table 18. Cognitive and Memory Enhancer Drugs Market Challenges
Table 19. Cognitive and Memory Enhancer Drugs Market Restraints
Table 20. Global Cognitive and Memory Enhancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Cognitive and Memory Enhancer Drugs Market Share by Players (2016-2021)
Table 22. Global Top Cognitive and Memory Enhancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2020)
Table 23. Ranking of Global Top Cognitive and Memory Enhancer Drugs Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Cognitive and Memory Enhancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cognitive and Memory Enhancer Drugs Product Solution and Service
Table 27. Date of Enter into Cognitive and Memory Enhancer Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2016-2021)
Table 31. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Cognitive and Memory Enhancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2016-2021)
Table 35. Global Cognitive and Memory Enhancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Cognitive and Memory Enhancer Drugs Product
Table 70. Pfizer Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Eisai Co Company Details
Table 73. Eisai Co Business Overview
Table 74. Eisai Co Cognitive and Memory Enhancer Drugs Product
Table 75. Eisai Co Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 76. Eisai Co Recent Development
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Cognitive and Memory Enhancer Drugs Product
Table 80. Allergan Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 81. Allergan Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Cognitive and Memory Enhancer Drugs Product
Table 85. Novartis Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Cognitive and Memory Enhancer Drugs Product
Table 90. Takeda Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Cognitive and Memory Enhancer Drugs Product
Table 95. Johnson & Johnson Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 96. Johnson & Johnson Recent Development
Table 97. Takeda Pharmaceutical Company Limited Company Details
Table 98. Takeda Pharmaceutical Company Limited Business Overview
Table 99. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Product
Table 100. Takeda Pharmaceutical Company Limited Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 101. Takeda Pharmaceutical Company Limited Recent Development
Table 102. AlternaScript Company Details
Table 103. AlternaScript Business Overview
Table 104. AlternaScript Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 105. AlternaScript Recent Development
Table 106. Cephalon Company Details
Table 107. Cephalon Business Overview
Table 108. Cephalon Cognitive and Memory Enhancer Drugs Product
Table 109. Cephalon Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 110. Cephalon Recent Development
Table 111. Ceretropic Company Details
Table 112. Ceretropic Business Overview
Table 113. Ceretropic Cognitive and Memory Enhancer Drugs Product
Table 114. Ceretropic Revenue in Cognitive and Memory Enhancer Drugs Business (2016-2021) & (US$ Million)
Table 115. Ceretropic Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cognitive and Memory Enhancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. Aricept Features
Figure 3. Exelon Features
Figure 4. Namenda Features
Figure 5. Razadyne Features
Figure 6. Provigil Features
Figure 7. Ritalin Features
Figure 8. Adderall Features
Figure 9. Others Features
Figure 10. Global Cognitive and Memory Enhancer Drugs Market Share by Application: 2020 VS 2027
Figure 11. Disease Treatment Case Studies
Figure 12. Academic Performance Case Studies
Figure 13. Athletic Performance Case Studies
Figure 14. Others Case Studies
Figure 15. Cognitive and Memory Enhancer Drugs Report Years Considered
Figure 16. Global Cognitive and Memory Enhancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Cognitive and Memory Enhancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Cognitive and Memory Enhancer Drugs Market Share by Regions: 2020 VS 2027
Figure 19. Global Cognitive and Memory Enhancer Drugs Market Share by Regions (2022-2027)
Figure 20. Global Cognitive and Memory Enhancer Drugs Market Share by Players in 2020
Figure 21. Global Top Cognitive and Memory Enhancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Cognitive and Memory Enhancer Drugs Revenue in 2020
Figure 23. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2022-2027)
Figure 25. North America Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Cognitive and Memory Enhancer Drugs Market Share by Type (2016-2027)
Figure 27. North America Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2027)
Figure 28. North America Cognitive and Memory Enhancer Drugs Market Share by Country (2016-2027)
Figure 29. United States Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Cognitive and Memory Enhancer Drugs Market Share by Type (2016-2027)
Figure 33. Europe Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2027)
Figure 34. Europe Cognitive and Memory Enhancer Drugs Market Share by Country (2016-2027)
Figure 35. Germany Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Cognitive and Memory Enhancer Drugs Market Share by Region (2016-2027)
Figure 45. China Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Cognitive and Memory Enhancer Drugs Market Share by Type (2016-2027)
Figure 53. Latin America Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2027)
Figure 54. Latin America Cognitive and Memory Enhancer Drugs Market Share by Country (2016-2027)
Figure 55. Mexico Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Cognitive and Memory Enhancer Drugs Market Share by Country (2016-2027)
Figure 61. Turkey Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Cognitive and Memory Enhancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Pfizer Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 65. Eisai Co Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 66. Allergan Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 68. Takeda Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 70. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 71. AlternaScript Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 72. Cephalon Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 73. Ceretropic Revenue Growth Rate in Cognitive and Memory Enhancer Drugs Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界のアルツハイマー病治療・診断市場規模・現状・予測（2021年-2027年） Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2…- 世界の認知システム市場規模・現状・予測（2021年-2027年） In 2020, the global Cognitive Systems market size will be US$ 5 million and it is expected to reach US$ 9 million by the end of 2026, with a CAGR of 11.5% during 2021-2026. This report focuses on the global Cognitive Systems status, future forecast, growth opportunity, key market, and key players. T…
- 世界の認知システム市場規模・現状・予測（2021年-2027年） In 2020, the global Cognitive Systems market size will be US$ 5 million and it is expected to reach US$ 9 million by the end of 2026, with a CAGR of 11.5% during 2021-2026. This report focuses on the global Cognitive Systems status, future forecast, growth opportunity, key market, and key players. T…
- 世界の記憶障害治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Memory Impairment Treatment Market The global Memory Impairment Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のコグニティブ無線市場規模・現状・予測（2021年-2027年） The cognitive radio market is segmented on the basis of components into software tools, hardware, and services. The software tools segment is expected to hold the largest market size during the forecast period. Software tools play an important role in the cognitive radio market. Components that are …